DOBUTAMINE MYLAN
DOBUTAMINE
Public price
1.463,00 MAD
Reimbursement base
1.463,00 MAD
Active substance
DOBUTAMINE
Reimbursable
What is this medicine?
DOBUTAMINE MYLAN contains DOBUTAMINE. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
DOBUTAMINE, SOLUTION A DILUER POUR PERFUSION, 250 MG, 1 BOITE 10 FLACON
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
SYMPATHOMIMETIQUE - G
Availability note
Reimbursable
Hospital price
1.197,00 MAD
Strength
250 MG
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
1 BOITE 10 FLACON
Type
G
Therapeutic class
SYMPATHOMIMETIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 1.463,00 MAD
Available presentations and strengths
Medicines with the same active substance
CARDIJECT
250 MG · 1 BOITE 1 FLACON
126,00 MAD
CARDIJECT 250 MG / 20 ML
250 MG / 20 ML · Flacon de 20 ml
126,00 MAD
DOBUTAMINE AGUETTANT 250MG/20ML
250 MG · 10 AMPOULE 20 ML
802,00 MAD
DOBUTAMINE AGUETTANT 250 MG
250 MG · 1 BOITE 10 FLACON
1.463,00 MAD
MEKARD 250 MG / 20 ML
250 MG / 20 ML · 10 ampoules de 20ml
1.463,00 MAD
